What is the treatment for erythema nodosum suspected to be linked to a Yersinia infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Erythema Nodosum Associated with Yersinia Infection

For erythema nodosum suspected to be linked to a Yersinia infection, doxycycline (100 mg twice daily orally) for 10-14 days is the recommended first-line treatment. 1, 2

Diagnosis Confirmation

  • Suspect Yersinia infection when erythema nodosum presents with:

    • Gastrointestinal symptoms (diarrhea, abdominal pain)
    • Fever
    • Tender, erythematous nodules on anterior lower extremities
    • Symptoms typically appear approximately 2 weeks after gastrointestinal symptoms 3
  • Diagnostic workup should include:

    • Stool culture for Yersinia
    • Serological testing for Yersinia antibodies
    • Complete blood count with differential
    • Erythrocyte sedimentation rate and/or C-reactive protein
    • Consider skin biopsy in atypical cases 4, 5

Treatment Algorithm

First-line Treatment:

  • Doxycycline 100 mg twice daily orally for 10-14 days 1, 2
    • Effective against Yersinia pestis and other Yersinia species
    • Continue until patient is afebrile for at least 48 hours

Alternative Treatments (for those who cannot take doxycycline):

  • Ciprofloxacin 500-750 mg twice daily orally for 10-14 days 6, 2
  • Trimethoprim-sulfamethoxazole 5 mg/kg (trimethoprim component) twice daily orally 6

For Severe Infections:

  • Combination therapy with a fluoroquinolone plus an aminoglycoside 6, 2
    • Ciprofloxacin 400 mg IV every 8 hours or 750 mg orally twice daily
    • Plus gentamicin 5 mg/kg IV or IM daily

Special Populations

Children:

  • For children ≥8 years: Doxycycline (2.2 mg/kg twice daily, maximum 100 mg per dose) 6, 2
  • For children <8 years: Trimethoprim-sulfamethoxazole or a fluoroquinolone based on weight 6

Pregnant Women:

  • Ciprofloxacin 500 mg every 8 hours or 750 mg every 12 hours orally 6
  • Avoid doxycycline due to risk of dental staining in the fetus 6, 2

Supportive Care for Erythema Nodosum

  • Bed rest and leg elevation to reduce discomfort
  • Nonsteroidal anti-inflammatory drugs for pain management 4, 5
  • Cool compresses for symptomatic relief

Important Clinical Considerations

  • Erythema nodosum associated with Yersinia infection is often self-limited but antimicrobial therapy can accelerate resolution and prevent complications 4, 5
  • Persistent Yersinia infection has been documented in some cases, potentially leading to reactive arthritis 7
  • Monitor for clinical improvement within 24-48 hours of starting treatment 2
  • Adjust therapy based on culture and sensitivity results when available

Potential Complications to Monitor

  • Development of reactive arthritis
  • Persistence of infection
  • Recurrence of erythema nodosum (may indicate persistent infection) 7

Early identification and prompt initiation of appropriate antibiotic treatment are crucial to prevent complications and reduce the duration of symptoms in patients with Yersinia-associated erythema nodosum.

References

Guideline

Treatment of Yersinia Pestis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Erythema nodosum: a sign of systemic disease.

American family physician, 2007

Research

Erythema nodosum.

World journal of pediatrics : WJP, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.